A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study aims to address the unmet medical need of participants with metastatic colorectal cancer (mCRC) who have previously been treated with irinotecan, oxaliplatin, a fluoropyrimidine, and bevacizumab, by demonstrating an overall survival prolongation with precemtabart tocentecan (Precem-TcT) as single agent or Precem-TcT in combination with bevacizumab compared to trifluoride/tipiracil (FTD-TPI) plus bevacizumab.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza zaawansowanego raka jelita grubego
- •Pacjent wcześniej otrzymywał określone leki (irinotekan, oksaliplatynę, fluoropirymidinę) i choroba się pogorszyła lub nie tolerował leczenia
- •Maksymalnie 2 poprzednie linie leczenia w przypadku zaawansowanego nowotworu
- •Dobry ogólny stan zdrowia (skala ECOG 0 lub 1)
- •Zdolność połykania tabletek doustnych
✗ Disqualifies
- •Niepowstrzymane efekty uboczne z wcześniejszych terapii
- •Historia innego nowotworu w ciągu ostatnich 3 lat
- •Przerzuty do mózgu
- •Perforacja lub przesączenie przewodu pokarmowego w ciągu ostatnich 6 miesięcy
- •Niedrożność jelit, niezowiniętość jelit lub zapalenie jelit (wrzodziejące zapalenie jelita grubego, choroba Crohna)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (21)
Rocky Mountain Cancer Centers, LLP- Aurora
Lone Tree, United States
Illinois Cancer Specialists
Arlington Heights, United States
Illinois CancerCare PC
Peoria, United States
Springfield Clinic
Springfield, United States
Profound Research LLC at Cancer and Leukemia Center
Sterling Heights, United States
Minnesota Oncology Hematology, P.A.
Saint Louis Park, United States
Missouri Cancer Associates - 150518964
Columbia, United States
SCRI Oncology Partners
Nashville, United States
Texas Oncology, P.A. - Abilene - 300210366
Abilene, United States
Texas Oncology-South Austin
Austin, United States
Texas Oncology DFW
Bedford, United States
Texas Oncology- San Antonio
San Antonio, United States
Texas Oncology, P.A. - Tyler
Tyler, United States
Virginia Oncology Associates
Newport News, United States
Blue Ridge Cancer Care - 300202915
Roanoke, United States
GenesisCare North Shore (Oncology)
St Leonards, Australia
Icon Cancer Centre Chermside
Chermside, Australia
University Health Network - Princess Margaret Cancer Centre
Toronto, Canada
National Cancer Center Hospital
Chūōku, Japan
Samsung Medical Center
Seoul, South Korea
China Medical University Hospital
Taichung, Taiwan
Trial contact
US Medical Information
Communication Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.